Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
ABBVRGX-314 by AbbVie for Diabetic Retinopathy: Likelihood of Approval
ABBVRGX-314 is under clinical development by AbbVie and currently in Phase II for Diabetic Retinopathy. According to GlobalData, Phase II...
Data Insights
ABBVRGX-314 by AbbVie for Diabetic Macular Edema: Likelihood of Approval
ABBVRGX-314 is under clinical development by AbbVie and currently in Phase II for Diabetic Macular Edema. According to GlobalData, Phase...